175 related articles for article (PubMed ID: 17963144)
1. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
2. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells.
Kowapradit J; Opanasopit P; Ngawhirunpat T; Rojanarata T; Ruktanonchai U; Sajomsang W
Drug Deliv; 2010 Jul; 17(5):301-12. PubMed ID: 20302396
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 1998 Jan; 51(1):35-46. PubMed ID: 9685902
[TBL] [Abstract][Full Text] [Related]
4. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
5. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2).
Kowapradit J; Opanasopit P; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Ruktanonchai U; Sajomsang W
AAPS PharmSciTech; 2008; 9(4):1143-52. PubMed ID: 19009354
[TBL] [Abstract][Full Text] [Related]
6. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
7. Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.
Dünnhaupt S; Barthelmes J; Köllner S; Sakloetsakun D; Shahnaz G; Düregger A; Bernkop-Schnürch A
Carbohydr Polym; 2015 Mar; 117():577-584. PubMed ID: 25498673
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
10. Chitosan ascorbate: a chitosan salt with improved penetration enhancement properties.
Rossi S; Marciello M; Sandri G; Bonferoni MC; Ferrari F; Caramella C
Pharm Dev Technol; 2008; 13(6):513-21. PubMed ID: 18720244
[TBL] [Abstract][Full Text] [Related]
11. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
12. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
Kotzé AF; Luessen HL; de Boer AG; Verhoef JC; Junginger HE
Eur J Pharm Sci; 1999 Jan; 7(2):145-51. PubMed ID: 9845799
[TBL] [Abstract][Full Text] [Related]
13. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
14. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
15. Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.
Wu SJ; Don TM; Lin CW; Mi FL
Mar Drugs; 2014 Nov; 12(11):5677-97. PubMed ID: 25421323
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells.
Weecharangsan W; Opanasopit P; Ngawhirunpat T; Apirakaramwong A; Rojanarata T; Ruktanonchai U; Lee RJ
Int J Pharm; 2008 Feb; 348(1-2):161-8. PubMed ID: 17714894
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-mediated siRNA delivery in vitro: effect of polymer molecular weight, concentration and salt forms.
Techaarpornkul S; Wongkupasert S; Opanasopit P; Apirakaramwong A; Nunthanid J; Ruktanonchai U
AAPS PharmSciTech; 2010 Mar; 11(1):64-72. PubMed ID: 20058108
[TBL] [Abstract][Full Text] [Related]
18. The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model-an in vitro model of the buccal epithelium.
Portero A; Remuñán-López C; Nielsen HM
Pharm Res; 2002 Feb; 19(2):169-74. PubMed ID: 11883644
[TBL] [Abstract][Full Text] [Related]
19. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1336-45. PubMed ID: 17373574
[TBL] [Abstract][Full Text] [Related]
20. In vitro permeability enhancement in intestinal epithelial cells (Caco-2) monolayer of water soluble quaternary ammonium chitosan derivatives.
Kowapradit J; Opanasopit P; Ngawhirunpat T; Apirakaramwong A; Rojanarata T; Ruktanonchai U; Sajomsang W
AAPS PharmSciTech; 2010 Jun; 11(2):497-508. PubMed ID: 20333490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]